Cardiff Oncology (CRDF) Gross Margin (2014 - 2019)
Cardiff Oncology's Gross Margin was 100.00% in Q4 2019, unchanged from 100.00% a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cardiff Oncology (CRDF) Gross Margin (2014 - 2019) Analysis & Trends
From Q3 2014 onward, Cardiff Oncology has reported Gross Margin for 22 quarters.
- Gross Margin has now increased for three consecutive years, with a five-year change of +5.51 percentage points (FY2014 to FY2019).
- In earlier years, Gross Margin was -57.92% in FY2018 (+200.49 pp), -258.41% in FY2017 (+95.71 pp), -354.12% in FY2016 (-252.98 pp) and -101.14% in FY2015 (-195.63 pp).
- Compared with a year earlier, Gross Margin was higher in seven of the last eight quarters, with an average year-over-year change of +196.40 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q4 2017 (a gain of 656.21 percentage points); the worst was Q4 2016 (a drop of 611.41 percentage points).
- Per Business Quant data, CRDF's Gross Margin in the three quarters before Q4 2019 was 100.00% (Q3 2019), 100.00% (Q2 2019) and 100.00% (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | 72.78% |
| 10 | Cardiff Oncology | 65.66 Mn | 31.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 100.00% |
| Sep 30, 2019 | 100.00% |
| Jun 30, 2019 | 100.00% |
| Mar 31, 2019 | 100.00% |
| Dec 31, 2018 | 100.00% |
| Sep 30, 2018 | 69.81% |
| Jun 30, 2018 | -82.84% |
| Mar 31, 2018 | -265.85% |
| Dec 31, 2017 | -107.35% |
| Sep 30, 2017 | -283.69% |
| Jun 30, 2017 | -231.54% |
| Mar 31, 2017 | -548.61% |
| Dec 31, 2016 | -763.56% |
| Sep 30, 2016 | -377.03% |
| Jun 30, 2016 | -293.71% |
| Mar 31, 2016 | -157.73% |
| Dec 31, 2015 | -152.15% |
| Sep 30, 2015 | -199.20% |
| Jun 30, 2015 | -63.33% |
| Mar 31, 2015 | -38.92% |
API Access
Cardiff Oncology Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();